Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Lilly

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lilly's 2013 sales performance.

Lilly

F-star hires ex-BMS immuno-oncology leader

Dr Kayitalire has over 20 years’ experience in oncology and immuno-oncology (IO) including spells at Celgene and Eli Lilly as well as BMS.

AZ says Farxiga cuts kidney disease in type 2 diabetes

AZ says Farxiga cuts kidney disease in type 2 diabetes AZ’s biggest competitor is Eli Lilly and Boehringer Ingelheim’s market-leading Jardiance (empagliflozin), which brought in $658m and around $2bn respectively for the two partners in 2018.

Lilly claims cluster headache first for CGRP drug Emgality

Lilly claims cluster headache first for CGRP drug Emgality Competition fierce in new class. Eli Lilly has pushed its nose in front of its rivals in the CGRP inhibitor market with the first FDA approval of a drug in the ... Emgality’s approval is based on a trial that compared the drug to placebo in 106

Latecomer Lilly preps its IL-23 drug for Crohn’s disease

Latecomer Lilly preps its IL-23 drug for Crohn’s disease Crohn’s could be an important indication for Lilly, as mirikizumab is very much playing catch-up in the IL-23 inhibitor category when it comes to psoriasis. ... positive data for mirikizumab in patients with chronic, inflammatory gastrointestinal

Amgen buys Danish partner Nuevolution for $167m

Amgen buys Danish partner Nuevolution for $167m a small-molecule interleukin-17a inhibitor that could rival injectable IL-17 biologics such as Novartis’ Cosentyx (secukinumab) and Eli Lilly’s Taltz (ixekizumab).

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics